Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
0.926
-0.014 (-1.45%)
Nov 21, 2024, 12:40 PM EST - Market open
Silo Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 0.07 | 0.07 | 0.07 | 0.07 | - | 0.04 | Upgrade
|
| Revenue | 0.07 | 0.07 | 0.07 | 0.07 | - | 0.04 | Upgrade
|
| Revenue Growth (YoY) | 0% | 0% | 1.18% | - | - | - | Upgrade
|
| Cost of Revenue | 0.01 | 0.01 | 0.01 | 0.01 | - | 0.03 | Upgrade
|
| Gross Profit | 0.07 | 0.07 | 0.07 | 0.07 | - | 0.01 | Upgrade
|
| Selling, General & Admin | 2.49 | 3.08 | 2.43 | 2.27 | 2.01 | 0.86 | Upgrade
|
| Research & Development | 1.63 | 0.85 | 1.29 | 0.69 | 0.03 | 0.06 | Upgrade
|
| Operating Expenses | 4.12 | 3.92 | 3.71 | 2.96 | 2.04 | 0.91 | Upgrade
|
| Operating Income | -4.06 | -3.86 | -3.65 | -2.89 | -2.04 | -0.9 | Upgrade
|
| Interest Expense | -0.01 | -0 | -0 | -0 | -0.27 | -0.06 | Upgrade
|
| Interest & Investment Income | 0.36 | 0.4 | 0.07 | 0 | 0.01 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | - | - | - | -0 | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | 0 | - | Upgrade
|
| EBT Excluding Unusual Items | -3.72 | -3.46 | -3.58 | -2.89 | -2.29 | -0.95 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0 | -0 | -0.44 | 6.91 | -0.01 | -0.03 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -0.03 | Upgrade
|
| Other Unusual Items | - | -0.17 | 0.11 | 0.17 | -0.36 | - | Upgrade
|
| Pretax Income | -3.71 | -3.63 | -3.91 | 4.18 | -2.67 | -1.01 | Upgrade
|
| Income Tax Expense | - | - | - | 0.02 | - | - | Upgrade
|
| Earnings From Continuing Operations | -3.71 | -3.63 | -3.91 | 4.16 | -2.67 | -1.01 | Upgrade
|
| Earnings From Discontinued Operations | -0.07 | -0.07 | -0 | -0.25 | -0.37 | - | Upgrade
|
| Net Income | -3.78 | -3.7 | -3.91 | 3.9 | -3.04 | -1.01 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | 1.4 | 0.07 | - | Upgrade
|
| Net Income to Common | -3.78 | -3.7 | -3.91 | 2.5 | -3.11 | -1.01 | Upgrade
|
| Shares Outstanding (Basic) | 3 | 3 | 2 | 2 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 3 | 2 | 2 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | 4.24% | 34.83% | 19.07% | 45.44% | 181.04% | -52.20% | Upgrade
|
| EPS (Basic) | -1.15 | -1.20 | -1.71 | 1.32 | -2.36 | -2.16 | Upgrade
|
| EPS (Diluted) | -1.15 | -1.20 | -1.71 | 1.30 | -2.78 | -2.16 | Upgrade
|
| Free Cash Flow | -3.83 | -3.22 | -3.5 | -2.28 | -1.16 | -0.79 | Upgrade
|
| Free Cash Flow Per Share | -1.17 | -1.05 | -1.53 | -1.19 | -0.88 | -1.69 | Upgrade
|
| Gross Margin | 91.90% | 91.90% | 91.90% | 92.98% | - | 32.49% | Upgrade
|
| Operating Margin | -5625.46% | -5347.41% | -5059.02% | -4059.33% | - | -2220.82% | Upgrade
|
| Profit Margin | -5247.34% | -5132.57% | -5420.86% | 3507.72% | - | -2497.71% | Upgrade
|
| Free Cash Flow Margin | -5307.06% | -4472.13% | -4850.94% | -3196.59% | - | -1957.96% | Upgrade
|
| EBITDA | - | - | - | - | - | -0.88 | Upgrade
|
| D&A For EBITDA | - | - | - | - | - | 0.02 | Upgrade
|
| EBIT | -4.06 | -3.86 | -3.65 | -2.89 | -2.04 | -0.9 | Upgrade
|
| Effective Tax Rate | - | - | - | 0.59% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.